Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation

BACKGROUND: Oral anticoagulation (OAC) therapy is associated with increased periprocedural risks after cardiac implantable electronic device (CIED) implantation. Patterns of anticoagulation management involving non–vitamin K antagonist oral anticoagulants (NOACs) have not been characterized. HYPOTHE...

Descripción completa

Detalles Bibliográficos
Autores principales: Black‐Maier, Eric, Kim, Sunghee, Steinberg, Benjamin A., Fonarow, Gregg C., Freeman, James V., Kowey, Peter R., Ansell, Jack, Gersh, Bernard J., Mahaffey, Kenneth W., Naccarelli, Gerald, Hylek, Elaine M., Go, Alan S., Peterson, Eric D., Piccini, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2017
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638096/
https://www.ncbi.nlm.nih.gov/pubmed/28543401
http://dx.doi.org/10.1002/clc.22726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638096/
https://www.ncbi.nlm.nih.gov/pubmed/28543401
http://dx.doi.org/10.1002/clc.22726

Ejemplares similares